This study is not yet recruiting. It focuses on depression and currently lists study information in Global.
This study is looking at test a new comprehensive management service package for older adults with two or more chronic conditions (multimorbidity) for people with depression. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment. This study may not offer a new treatment, and its main value is helping researchers learn from follow-up information that may improve future care.
The official record does not clearly spell out the visit format, but it appears to be coordinated directly by the research team. Participation appears to involve questionnaires, interviews, or regular check-ins about day-to-day experience. The main fit is usually matching the main diagnosis and being able to understand the study and consent, while common reasons not to take part include major medical issues that could make participation unsuitable and other factors that could make participation unsuitable. The official record does not list a formal phase, which usually means this is focused more on feasibility, delivery, or support than a standard drug-development stage.
This study may matter because it adds public evidence around depression. HopeStage presents it as a starting point for understanding the study, checking the official source, and preparing questions with a care team.
This page links back to the public source record so people can verify details directly with the registry and research team.
If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.
Open source recordThis form records your interest so HopeStage can follow up with practical guidance. It is not a medical eligibility decision and it does not guarantee a study spot.
Taking part may give access to a new approach being evaluated.
It requires regular follow-up, often through questionnaires or interviews.
Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com
This study is exploring medication or study treatment for people with depression. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed.
This study is sponsored by Xuanwu Hospital, Beijing. Based on the sponsor name or official registry information, it appears to be a hospital or academic medical center. You should verify the details in the official registry record.
This study may involve medication or study treatment, study visits, and assessments. The time commitment is multiple visits or assessments. The study phase is not available in HopeStage data. Check the official source record to see whether a phase is listed. Enrollment is not available in HopeStage data. HopeStage cannot say whether a study is safe or right for you. Before joining, ask the research team about possible risks, time commitment, visits, side effects, compensation, safety monitoring, and whether participation may affect your current care.
Use the official source record linked on this page to check the full study description, recruitment status, eligibility criteria, locations, sponsor information, phase, enrollment, contact details, and any listed risks or requirements.